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Abstract 
Objective: We perform reconstruction using frozen tumor bone treated by liquid nitrogen after 
excision of malignant bone tumors. To prevent postoperative infection, we use iodine-coated 
implants that we developed. The purpose of this study is to compare the outcome of 
reconstruction using frozen autograft with non-coated implants (group N) and iodine-coated 
implants (group I). 
Methods: Sixty-two patients were included in group N. The mean age was 31.9±2.3 years. A 
total of 20 patients died and two were lost to follow-up, averaging 20.0±2.9 months 
post-operatively, leaving 40 patients available for an assessment at a mean of 79.1±5.8 months 
post-operatively. There were 38 patients in group I. The mean age was 29.8±3.9 years. The 
mean follow-up period was 32.1±3.0 months. All patients were alive at the latest follow-up. 
Survival of frozen bone was determined by Kaplan-Meier analysis.  
Results: In group N, survival of frozen bone was 80.7±6.0% and 57.4±10.2% at 5 and 10 
years, respectively. Complications were encountered in 31 of 62 patients (50.0%), including 
deep infection in 10 (16.1%), fracture in 11 (17.7%), local soft-tissue recurrence in six (9.7%), 
and bone absorption in four (6.5%). In group I, survival of frozen bone was 86.7±6.3% at 5 
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years. Complications were encountered in 8 of 38 patients (21.1%), including deep infection in 
one (2.6%), fracture in four (10.5%), local soft-tissue recurrence in two (5.3%), and bone 
absorption in one (2.6%). There was a significantly lower infection rate in group I (P=0.032).  
Conclusion: Reconstruction using frozen autograft combined with iodine coated-implants for 
patients with malignant bone tumor is very useful method in which good limb function can be 
gained with minimized risk of infection.  
 
Mini-abstract 
Reconstruction using frozen tumor bone treated by liquid nitrogen combined with iodine 
coated-implants for patients with malignant bone tumor is very useful method in which good 
limb function can be gained with minimized risk of infection. 
 




Limb salvage surgery is a standard treatment for malignant musculoskeletal tumors with the 
development of a combined modality therapy (1,2). The reconstruction methods following 
tumor excision in limb salvage operation are tumor prosthesis (2), autograft (1,3), allograft (4), 
distraction osteogenesis (5), and vascularized fibular graft (6). Biological reconstruction by 
recycling the resected tumor-bearing bone is popular in Asian countries. Before re-implantation, 
the bone is subject to treatment including irradiation (1,7), pasteurization (8,9), or freezing with 
liquid nitrogen (3,10,11). In 1999, we developed and performed a re-implantation technique 
using frozen autografts treated with liquid nitrogen. The advantages of liquid nitrogen treatment 
include the following: simplicity, low cost, maintenance of osteoinductive and osteoconductive 
properties, perfect fit between graft and host bone, no disease transmission, no immunological 
rejection, preservation of the cartilage matrix, no need for a bone bank, no requirement of 
special equipment and strict thermal control, easy attachment of tendons and ligaments to bone, 
no harmful denatured substances, early revitalization and cryoimmunological effects (11).  
 Post-operative infection is one of the most serious complications for recycled autografts. We 
developed iodine-coated implants to prevent post-operative infection in 2005 (12). The anodic 
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oxide film was produced electrically, and use of a povidone-iodine electrolyte resulted in the 
formation of an adhesive porous anodic oxide with the antiseptic properties of iodine. The 
thickness of the anodic oxide film was between 5 and 10 μm, with more than 100,000 
pores/mm2 and capacity to support 10-12 μg/cm2 iodine. The durability of the implants is not 
influenced, because it is just a coating. We have previously reported the clinical effects of 
iodine-coated implants (13,14,15).  
 The purpose of this study was to compare the outcomes of reconstruction using frozen 
autograft with non-coated implants (group N) and iodine-coated implants (group I).  
  
Patients and methods 
 Between 1999 and 2008, we recruited 62 patients with bone tumors, who underwent 
reconstruction using frozen autografts with non-coated implants (group N). The mean age of the 
patients was 31.9 ± 2.3 years (range, 7 to 72). Thirty-nine patients were male and 23 were 
female. A total of 20 patients died and two were lost to follow-up, at a mean of 20.0 ± 2.9 
months (range, 2 to 48) post-operatively. Therefore, 40 patients were available for assessment at 
a mean of 79.1 ± 5.8 months (range, 11 to 158) post-operatively. The diagnoses included 38 
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cases of osteosarcoma, seven of metastasis and chondrosarcoma, four of Ewing’s sarcoma, two 
of malignant fibrous histiocytoma (MFH) and one case each of rhabdomyosarcoma, 
leiomyosarcoma, chordoma, and malignant hemangiopericytoma. The affected sites included 33 
femur, 11 tibia, 10 pelvis, six humerus, and one radius and calcaneus. The following types of 
implants were used with frozen bone: 22 nails, 16 plates, 10 knee prostheses, eight hip 
prostheses, four screws, and two shoulder prostheses.  Between 2008 and 2014, we included 
38 patients, who underwent reconstruction using frozen autografts with iodine-coated implants 
(group I). The mean age of the patients was 29.8 ± 3.9 years (range, 6 to 79). Twenty-two 
patients were male and 16 were female. The mean follow-up period was 32.1 ± 3.0 months 
(range, 7 to 68). All patients were alive at the most recent follow-up. The diagnoses were 29 
cases of osteosarcoma, three of metastasis, two of chondrosarcoma, and one each of Ewing’s 
sarcoma (Fig. 1a-g), fibrosarcoma, MFH and adamantinoma. The affected sites included 19 
femur, 12 tibia, three pelvis and humerus, and one radius. The following types of iodine-coated 
implants were used with frozen bone: 33 plates, 3 knee prostheses, and each one hip and 
shoulder prosthesis. The survival of frozen bone was determined by Kaplan-Meier analysis, and 
inter-group survival differences were determined using a log-rank test. The survival of frozen 
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bone was defined as the period until the surgical removal of the recycled bone. Post-operative 
complications during follow-up were evaluated in both groups. A Fisher's exact test was 
performed to examine post-operative complications such as infection, fracture, recurrence, and 
bone absorption. The function of the affected limbs of 46 patients in group N and 34 patients in 
group I, who were followed for at least one year, was evaluated with the Musculoskeletal Tumor 
Society (MSTS) functional scoring system (16). Functional outcomes in the two study groups 
were compared using a t test. Statistical analyses were performed using IBM SPSS Statistics 
software, version 19 (IBM SPSS, Armonk, NY, USA). A P value of less than 0.05 was 
considered significant.  
  
Results 
 Between group N and group I, there was no significant difference with regard to the diagnosis 
and affected sites.  
 In group N, the survival rate of frozen bone was 80.7 ± 6.0% and 57.4 ± 10.2% at 5 and 10 
years, respectively (Fig. 2). Complications were encountered in 31 of 62 patients (50.0%), 
including 10 cases of deep infection (16.1%), 11 of fracture (17.7%), six of local soft-tissue 
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recurrence (9.7%), and four of bone absorption (6.5%). Most infections had occurred within 6 
months during postoperative chemotherapy. Frozen autografts were removed in 14 patients 
because of infection (6 cases), fracture (5 cases), tumor recurrence (2 cases), and bone 
absorption (1 case) (Table 1). The mean period of graft removal was 30.3 ± 10.2 months (range, 
3.6 to 114.5).  
 In group I, survival of frozen bone was 86.7 ± 6.3% at 5 years (Fig. 2). Complications were 
encountered in 8 of 38 patients (21.1%) including one case of deep infection (2.6%), four of 
fracture (10.5%), two of local soft-tissue recurrence (5.3%), and one of bone absorption (2.6%). 
Frozen autografts were removed in four patients because of infection (1 case), fracture (2 cases), 
and tumor recurrence (1 case) (Table 1). The mean period of graft removal was 13.3 ± 4.1 
months (range, 5.0 to 24.1). On Kaplan-Meier survival analysis, there was no significant 
difference (P=0.872) (Fig. 2). However, there was a significantly lower infection rate in group I 
(P=0.032) (Table I). The mean MSTS score was 85.2% in group N and 92.8% in group I. These 




 The infection rate of group I was significantly lower for the reconstructions using frozen 
autografts, although there was no difference in the survival rate compared to previous recycled 
bone, such as allografts (17), irradiated autografts (18), pasteurized autografts (19), and frozen 
autografts (20) (Table 2). The results suggest that iodine-coated implants had antibacterial 
effects. Although the survival rate of the frozen bone was not significantly different using 
iodine-coated implants compared to frozen autografts alone, we expect that the survival rate 
may be improved by increasing the number of iodine-coated implant cases. The iodine coating 
is a revolutionary technology for implants because of its antibacterial efficacy. The 
iodine-coated implants make it possible for postoperative infection to be controlled. In 5 years, 
iodine-coated implants will be made available commercially in Japan. 
  
 In terms of functionality, the average MSTS scores were 90%, 62.6%, 78.7%, and 79.2% in 
allograft, irradiated autograft, pasteurized autograft and frozen autograft, respectively (18-21). 
In this study, the average of functional score was 85.2% and 92.8% for group N and group I, 
respectively. Therefore, functional outcomes for both groups were favorable compared to the 
other recycled bone techniques. Group I in particular displayed good functional tendencies, 
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although there was no significant difference in the MSTS scores between group N and group I 
(P=0.12). 
 There are a few limitations to note in this study. First, a relatively small number of patients 
limit the interpretation of our results. However, these numbers are comparable or greater than 
previous reports using recycled bone grafts. Second, group N represents our previous 
treatment method, whereas group I represents the treatment group after our 
development of iodine coating. In other words, the two groups may not be compared 
directly, and the historical nature of this study limits its level of evidence. Thirds, 
this study was retrospective and the study period included a relatively broad time frame. As 
such, patient selection between each group was not standardized. Fourth, the follow-up duration 
of group I was shorter than group N. More long-term follow-up is needed in group I.  
 In conclusion, the study showed that reconstruction using frozen autograft combined with 
iodine-coated implants for patients with malignant bone tumor is a very useful method in which 
good limb function can be gained with minimal risk of infection.  
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Legends 
Figure 1: A 14 year-old boy with pelvic Ewing’s sarcoma. 
 a: On initial MRI, there was a huge extraskeletal tumor mass (arrowhead). 
 b: On post-chemotherapeutic MRI, the extraskeletal mass had shrunk (arrowhead). 
 c: We performed reconstruction using a frozen autograft with iodine-coated implants after 
tumor excision. 
 d: The immediate post op computed tomography: osteotomy site was shown at sacrum 
(arrow) 
 e: Radiograph at 20 months after surgery. 
 f: Computed tomography showed excellent union between the host and frozen bone (arrow). 
 g: He is able to run normally at 20 months after surgery. 
Figure 2: A Kaplan-Meier curve showing the survival rate of the frozen autografts according to 
the coating of implants.  
  
Table 1: Complications and limb function according to the implant coating. 









 Variables Non-coating Coating p-value 
Infection   .032 
yes      11 1  
no      52 37  
Fracture   .247 
yes      11 4  
no      51 34  
Recurrence   .351 
yes      6 2  
no      56 36  
Bone absorption   .368 
yes      4 1  
no      58 37  
MSTS    















score 5-year 10-year 
Biau et al17) Allograft 68 % 33 % 73 % 23 % 27 % 23 % 90 % 
Kim et al18) Irradiated autograft NA 43 % 87 % 22 % 9 % NA 62.6 % 
Jeon et al19) Pasteurized autograft 77 % NA 38 % 23 % 0 % 8 % 78.7 % 
Paholpak et al20) Frozen autograft NA NA 42 % 25 % 8 % 8 % 79.2 % 
Current series Group N 80.7% 57.4 % 50.0% 16.1 % 17.7 % 6.5 % 85.2 % 
Group I 86.7 % NA 21.1 % 2.6 % 10.5 % 2.6 % 92.8 % 
NA, not assessed 
Table 2 
